TuesdayNov 14, 2023 12:23 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Featured in Bell2Bell Podcast

Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Longeveron’s CEO Wa’el Hashad joined the program to introduce the company and its business model. “Longeveron is a cell therapy-based biotech company. It was established in 2014 as a spin-off from a technology that was developed at the University of Miami School of Medicine by a renowned scientist and cardiologist, Dr. Josh Hare,” Hashad said. “Josh has been…

Continue Reading

TuesdayNov 14, 2023 9:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates

PaxMedica is developing PAX-101, which utilizes the company’s proprietary source of suramin sodium, for the treatment of ASD (Autism Spectrum Disorder) There is no FDA-approved treatment for the core symptoms of autism, even though the rates of autism spectrum disorder have jumped significantly from 2000 to 2020 ASD is characterized by deficits in social communication, restricted and repetitive patterns of behavior, and significant impairment in functioning, three core aspects of the disease that PaxMedica aims to address The company announced positive topline results from a Phase 2 study evaluating PAX-101 as a potential treatment for ASD and hopes to replicate…

Continue Reading

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

Continue Reading

MondayNov 13, 2023 3:21 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Releases Q3 2023 Financial Results

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is reporting its numbers for the third quarter of 2023. Highlights of the report included revenue of $2.6 million for the quarter, an increase of 50% sequentially from Q2 and an increase of 51% on a year over year basis. Commercial revenue increased by 62% year over year and constituted 70% of total revenue over the last four quarters, up from 50% over the prior four quarters. Q3 bookings totaled $2.9 million, up 53% on a year-to-year basis with Q3 representing the company’s sixth consecutive quarter of year…

Continue Reading

MondayNov 13, 2023 2:57 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Catering to Global EV Industry Supply Chain

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2), a strategic minerals company, has centered its corporate mission around locating and developing economic properties within the advanced materials space to cater to the rapidly growing needs of the global electric vehicle industry supply chain. “In mid-August, Reflex Advanced Materials announced that it would be issuing 100,000 new common shares of its capital, the penultimate step needed to fulfil a mineral property option payment agreement the company had entered in 2021 for its Zigzag lithium project. Located near Crescent Lake, Ontario and consisting of eight mining claims totaling approximately 2,710 hectares, the Zigzag…

Continue Reading

MondayNov 13, 2023 2:18 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Earnings Call, Plans to Report Q3 2023 Financial Results

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has scheduled a call and webcast for tomorrow to discuss its financial results for Q3 2023, the period ended Sept. 30, 2023. The call is slated to begin at 10 a.m. ET. According to the announcement, financial results for the company will be released prior to the call. The call, which will include a Q&A session, will be hosted by SuperCom management. Those wanting to access the call can dial 888-506-0062 (toll free in the United States), 1-809-423-853 (toll free in Israel) or…

Continue Reading

MondayNov 13, 2023 12:28 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Expansion of US Battery Operations

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a new high-energy facility in Fullerton, California, which expands the company’s overall U.S. footprint, including EV battery development and production capabilities. According to the announcement, the new Southern California facility is dedicated to producing next-generation American-made EV battery packs, a critical component to the company’s commitment to zero emissions. Mullen’s high-energy pilot facility in Monrovia, California, will be consolidated with the recently purchased Romeo Power assets at the company’s new high-energy and high-volume battery pack production facility in Fullerton, California. “We are one step closer to fulfilling our…

Continue Reading

MondayNov 13, 2023 12:15 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Discusses ‘Responsible Innovation’ in Exclusive Benzinga Interview

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, was spotlighted in a recent exclusive Benzinga interview. During the interview, Diamond Lake Minerals CEO Brian Esposito talked with host Jordan Robinson about the company, which specializes in the development and support of digital assets and SEC-registered security tokens. During the interview, Esposito explained that the goal of the company is to responsibly innovate and develop valuable traditional businesses and successfully combine them with the future of money: digital assets. He noted that his new role as…

Continue Reading

MondayNov 13, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) on Mission to Bring Rare Earth Separation Facilities to North America

The rare earth metals market was valued at $5.3 billion in 2021 and is projected to grow at a CAGR of 12.3%, resulting in a value of $9.6 billion by 2026 The growing tensions between China and the United States make it more important than ever for sustainable REE (Rare Earth Element) separation operations that do not depend on China, and Ucore's RapidSX(TM) technology is key to the answer Ucore plans is developing its first Strategic Metals Complex for REE separation in Louisiana The demand for rare earth elements (“REE”) is expected to surge as the electric vehicle and renewable…

Continue Reading

MondayNov 13, 2023 10:07 am

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s 2023 Scientific Sessions

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-Related Frailty, is reporting on data from a long-term study. According to the announcement, extended long-term, follow-up data from Longeveron’s  ELPIS I trial of Lomecel-B(TM) for patients with hypoplastic left heart syndrome (“HLHS”) is being presented as a poster at the annual Scientific Sessions of the American Heart Association (AHA); those sessions are being held this week, Nov. ­11­-13, 2023, in Philadelphia. The poster for the sessions is titled “Long-Term Transplant-Free Survival Is Improved in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered